Late-breaking data for Roche's BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis.
In: Global Data Point, 2023-10-14
Zeitungsartikel
Zugriff:
Titel: |
Late-breaking data for Roche's BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis.
|
---|---|
Zeitschrift: | Global Data Point, 2023-10-14 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|